Abstract
Between 2004 and 2008, the US National Institutes of Health Molecular Libraries and Imaging initiative pilot phase funded 10 high-throughput screening centers, resulting in the deposition of 691 assays into PubChem and the nomination of 64 chemical probes. We crowdsourced the Molecular Libraries and Imaging initiative output to 11 experts, who expressed medium or high levels of confidence in 48 of these 64 probes.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening
Scientific Reports Open Access 24 November 2016
-
Badapple: promiscuity patterns from noisy evidence
Journal of Cheminformatics Open Access 28 May 2016
-
The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation
Journal of Cheminformatics Open Access 01 February 2014
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Change history
17 June 2009
In the version of this article initially published, the phrase "Though MLI and its pilot phase budget and superficially modest productivity were subject to industrial criticism" originally cited reference 3, but should cite reference 2. The error has been corrected in the HTML and PDF versions of the article.
References
Austin, C.P., Brady, L.S., Insel, T.R. & Collins, F.S. Science 306, 1138–1139 (2004).
Kaiser, J. Science 321, 764–766 (2008).
Hopkins, A.L. & Polinsky, A. Ann. Rep. Med. Chem. 41, 425–437 (2006).
Polanyi, M. Personal Knowledge: Towards a Post-Critical Philosophy (University of Chicago Press, Chicago, 1974).
Rishton, G.M. Drug Discov. Today 2, 382–384 (1997).
Roche, O. et al. J. Med. Chem. 45, 137–142 (2002).
McGovern, S.L., Helfand, B.T., Feng, B. & Shoichet, B.K. J. Med. Chem. 46, 4265–4272 (2003).
Seidler, J., McGovern, S.L., Doman, T.N. & Shoichet, B.K. J. Med. Chem. 46, 4477–4486 (2003).
Young, S.M. et al. J. Biomol. Screen. 10, 374–382 (2005).
Kramer, J.A., Sagartz, J.E. & Morris, D.L. Nat. Rev. Drug Discov. 6, 636–649 (2007).
Lipinski, C.A., Lombardo, F., Dominy, B.W. & Feeney, P.J. Adv. Drug Deliv. Rev. 23, 3–25 (1997).
Keserü, G.M. & Makara, G.M. Nat. Rev. Drug Discov. 8, 203–212 (2009).
Norinder, U. & Haeberlein, M. Adv. Drug Deliv. Rev. 54, 291–313 (2002).
Ajay, A, Walters, W.P. & Murcko, M.A. J. Med. Chem. 41, 3314–3324 (1998).
Sadowski, J. & Kubinyi, H. J. Med. Chem. 41, 3325–3329 (1998).
Teague, S.J., Davis, A.M., Leeson, P.D. & Oprea, T.I. Angew. Chem. Int. Ed. 38, 3743–3748 (1999).
Hann, M.M., Leach, A.R. & Harper, G. J. Chem. Inf. Comput. Sci. 41, 856–864 (2001).
Oprea, T.I. & Matter, H. Curr. Opin. Chem. Biol. 8, 349–358 (2004).
Vaz, R.J. & Klabunde, T. Antitargets (Wiley-VCH, Weinheim, Germany, 2008).
Tetko, I.V., Tanchuk, V.Y. & Villa, A.E. J. Chem. Inf. Comput. Sci. 41, 1407–1421 (2001).
Oprea, T.I. J. Braz. Chem. Soc. 13, 811–815 (2002).
Inglese, J., Shamu, C.E. & Guy, R.K. Nat. Chem. Biol. 3, 438–441 (2007).
Rishton, G.M. Curr. Opin. Chem. Biol. 12, 340–351 (2008).
Adams, C.P. & Brantner, V.V. Health Aff. (Millwood) 25, 420–428 (2006).
Leo, A. Chem. Rev. 93, 1281–1306 (1993).
Howe, J. Wired http://www.wired.com/wired/archive/14.06/crowds.html (2006).
Chesbrough, H.W. Open Innovation: The New Imperative for Creating and Profiting from Technology (Harvard Business School Press, Boston, 2003).
Howe, J. Crowdsourcing: Why the Power of the Crowd Is Driving the Future of Business (Crown Business, New York, 2008).
Surowiecki, J. The Wisdom of Crowds: Why the Many Are Smarter Than the Few and How Collective Wisdom Shapes Business, Economies, Societies and Nations (Doubleday, New York, 2004).
Acknowledgements
We thank E. Bolton (NIH/PubChem) for promptly answering questions related to the MLI. B.K. Shoichet (University of California, San Francisco) voted on some of these chemical probes, as reflected in Figure 1 and Supplementary Table 1. C.A. Taylor, J. Feng, R. Yang, Y. Tang, D. Kuster and C.M.W. Ho (all from Washington University School of Medicine) contributed to the probe evaluation vote of G. Marshall. J. Besnard (University of Dundee) contributed to the vote of A. Hopkins. This work was supported by NIH grant 1U54MH084690 (to the University of New Mexico).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
T.O. is the founder and CEO of Sunset Molecular Discovery LLC, and co-founder of Drug4Cast LLC; both companies provide services related to the pharmaceutical sector. T.O. also serves on the Scientific Advisory Board for ChemDiv, Inc. L.A.S. is a founder of IntelliCyt, a company that provides hardware and software for the HyperCyt HTS flow cytometry platform.
Supplementary information
Supplementary Table
Supplementary Table 1 (XLS 828 kb)
Rights and permissions
About this article
Cite this article
Oprea, T., Bologa, C., Boyer, S. et al. A crowdsourcing evaluation of the NIH chemical probes. Nat Chem Biol 5, 441–447 (2009). https://doi.org/10.1038/nchembio0709-441
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio0709-441
This article is cited by
-
A solution to the single-question crowd wisdom problem
Nature (2017)
-
Badapple: promiscuity patterns from noisy evidence
Journal of Cheminformatics (2016)
-
mQC: A Heuristic Quality-Control Metric for High-Throughput Drug Combination Screening
Scientific Reports (2016)
-
Dark chemical matter as a promising starting point for drug lead discovery
Nature Chemical Biology (2015)
-
The use of 2D fingerprint methods to support the assessment of structural similarity in orphan drug legislation
Journal of Cheminformatics (2014)